Results 151 to 160 of about 2,156 (171)

Matrix metalloproteinase inhibition as a novel anticancer strategy: a review with special focus on batimastat and marimastat.

Pharmacology and Therapeutics, 1997
H. Rasmussen, P. McCann
semanticscholar   +1 more source

Prospective, randomized, double-blind, placebo-controlled trial of marimastat after response to first-line chemotherapy in patients with small-cell lung cancer: a trial of the National Cancer Institute of Canada-Clinical Trials Group and the European Organization for Research and Treatment of Cancer

Journal of Clinical Oncology, 2002
F. Shepherd, G. Giaccone, L. Seymour, C. Debruyne, A. Bezjak, V. Hirsh, M. Smylie, S. Rubin, H. Martins, A. Lamont, M. Krzakowski, A. Sadura, B. Zee   +12 more
semanticscholar   +1 more source

Towards kit-like 18F-labeling of marimastat, a noncovalent inhibitor drug for in vivo PET imaging cancer associated matrix metalloproteases

, 2011
Ying Li, Richard Ting, C. Harwig, U. A. D. Keller, C. Bellac, P. Lange, J. Inkster, P. Schaffer, M. Adam, T. Ruth, C. Overall, D. Perrin   +11 more
semanticscholar   +1 more source

Labeling and enrichment of Arabidopsis thaliana matrix metalloproteases using an active-site directed, marimastat-based photoreactive probe.

Bioorganic & Medicinal Chemistry, 2012
Janina Lenger, F. Kaschani, T. Lenz, Christian Dalhoff, Joji Grace Villamor, H. Köster, N. Sewald, R. V. D. van der Hoorn   +7 more
semanticscholar   +1 more source

Phase II trial of temozolomide plus the matrix metalloproteinase inhibitor, marimastat, in recurrent and progressive glioblastoma multiforme.

Journal of Clinical Oncology, 2002
M. Groves, V. Puduvalli, K. Hess, K. Jaeckle, Pamela Peterson, W. Yung, V. Levin   +6 more
semanticscholar   +1 more source

Randomized, double-blind, placebo-controlled trial of marimastat in glioblastoma multiforme patients following surgery and irradiation★

Journal of Neuro-Oncology, 2006
V. Levin, S. Phuphanich, W. K. Alfred Yung, P. Forsyth, R. Maestro, J. Perry, G. Fuller, M. Baillet   +7 more
semanticscholar   +1 more source

Marimastat

2007
openaire   +1 more source

Marimastat promising in advanced cancers

Inpharma Weekly, 1996
openaire   +1 more source

A pilot study of the safety and effects of the matrix metalloproteinase inhibitor marimastat in gastric cancer.

European Journal of Cancer, 1999
G. Tierney, N. Griffin, R. Stuart, H. Kasem, K. Lynch, J. Lury, P. Brown, A. Millar, R. Steele, S. Parsons   +9 more
semanticscholar   +1 more source

Marimastat

2008
openaire   +1 more source